ACUTE PYELONEPHRITIS
Clinical trials for ACUTE PYELONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE PYELONEPHRITIS trials appear
Sign up with your email to follow new studies for ACUTE PYELONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail takes on superbugs in hospital infections
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for serious infections like urinary tract, kidney, lung, and abdominal infections caused by carbapenem-resistant bacteria. About 126 adults parti…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New antibiotic cocktails show promise against tough urinary infections
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against a standard treatment for complicated urinary tract infections and kidney infections in adults. The goal was to see if the new drugs work better at clearing the infection and i…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New antibiotic duo takes on tough UTIs in head-to-head trial
Disease control CompletedThis study tested a new antibiotic called cefepime-zidebactam against a standard antibiotic (meropenem) in about 530 adults hospitalized with complicated urinary tract infections or kidney infections. The goal was to see if the new drug works as well and is safe. Participants rec…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Could a pill replace IV antibiotics for tough UTIs?
Disease control CompletedThis study tested an oral antibiotic called tebipenem against a standard IV antibiotic in 1,690 hospitalized adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the oral drug works as well as the IV drug at curing the infection and …
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:03 UTC